Image
Back to top
Prof Lluís Puig
Director of Dermatology
Professor Lluís Puig is Director of Dermatology at the Hospital de la Santa Creu i Sant Pau, Barcelona, Spain, and Professor of Dermatology at the University of Barcelona, Spain.
For over 15 years, Professor Puig’s clinical research has focused on the treatment of psoriasis with biological agents. He has worked on over 85 clinical trials and research projects, primarily as the principal investigator.
Professor Puig also serves on several editorial boards and has published over 300 papers in journals such as The New England Journal of Medicine, Journal of the European Academy of Dermatology and Venereology, and British Journal of Dermatology.
He is a member of multiple national and international scientific societies, has been a member of the board of directors of the European Academy of Dermatology and Venereology (EADV), and is co-Chair of the Psoriasis Task Force of the EADV, Member of the GRAPPA Education and Steering Committees, and Board Member of the International Psoriasis Council.
0 resources
Infographic
This infographic outlines the six proposed stages of HS pathogenesis and highlights the immune cells involved in the progression of HS
EU-DA-2400034
File
The symptoms of HS go beyond skin deep. For the true burden of HS and to facilitate holistic care, see the full list of symptoms that patients may experience
EU-DC-2400044
File
Can you spot the signs and symptoms of HS? Take a look at our algorithm that aims to aid a diagnosis of HS
EU-DC-2400044
File
Developed with input from HS experts, this guide provides practical information to help you successfully recognize, manage and communicate with patients
EU-DC-2400044
File10 min read
Did you know that gender influences the quality of life of a patient with psoriasis1 ? This material highlights the specific needs that women living with...
EU-DA-2400171
File10 min read
Did you know that 50% of pregnancies are unplanned?1
This material presents a summary of why timely discussions about family planning between healthcare...
EU-DA-2400173